dehydroepiandrosterone has been researched along with Sarcopenia in 4 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Sarcopenia: Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Postmenopausal women with sarcopenia were more likely to have lower DHEA levels and higher follistatin levels, and postmenopausal women with osteoporosis were more likely to have lower oxytocin levels." | 8.02 | Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women. ( Chen, M; Cheng, Q; Du, Y; Jiang, X; Li, H; Shi, H; Tang, W; Wu, X; Xu, C; Zhang, X, 2021) |
| "Postmenopausal women with sarcopenia were more likely to have lower DHEA levels and higher follistatin levels, and postmenopausal women with osteoporosis were more likely to have lower oxytocin levels." | 4.02 | Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women. ( Chen, M; Cheng, Q; Du, Y; Jiang, X; Li, H; Shi, H; Tang, W; Wu, X; Xu, C; Zhang, X, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Y | 1 |
| Xu, C | 1 |
| Shi, H | 1 |
| Jiang, X | 1 |
| Tang, W | 1 |
| Wu, X | 1 |
| Chen, M | 1 |
| Li, H | 1 |
| Zhang, X | 1 |
| Cheng, Q | 1 |
| Huang, K | 1 |
| Cai, HL | 1 |
| Bao, JP | 1 |
| Wu, LD | 1 |
| Fragala, MS | 1 |
| Dam, TT | 1 |
| Barber, V | 1 |
| Judge, JO | 1 |
| Studenski, SA | 1 |
| Cawthon, PM | 1 |
| McLean, RR | 1 |
| Harris, TB | 1 |
| Ferrucci, L | 1 |
| Guralnik, JM | 1 |
| Kiel, DP | 1 |
| Kritchevsky, SB | 1 |
| Shardell, MD | 1 |
| Vassileva, MT | 1 |
| Kenny, AM | 1 |
| Vitale, G | 1 |
| Cesari, M | 1 |
| Mari, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective Trial to Evaluate the Utility of Focused Frailty Interventions on Patients With Advanced Heart Failure[NCT03574662] | 1 participants (Actual) | Interventional | 2018-05-04 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for dehydroepiandrosterone and Sarcopenia
| Article | Year |
|---|---|
Dehydroepiandrosterone and age-related musculoskeletal diseases: Connections and therapeutic implications.
Topics: Aged; Aging; Dehydroepiandrosterone; Humans; Musculoskeletal Diseases; Osteoporosis; Sarcopenia | 2020 |
Aging of the endocrine system and its potential impact on sarcopenia.
Topics: Aged; Aging; Dehydroepiandrosterone; Endocrine System; Hormone Replacement Therapy; Humans; Muscle, | 2016 |
2 other studies available for dehydroepiandrosterone and Sarcopenia
| Article | Year |
|---|---|
Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women.
Topics: Aged; Aged, 80 and over; Cross-Sectional Studies; Dehydroepiandrosterone; Female; Follistatin; Human | 2021 |
Strength and function response to clinical interventions of older women categorized by weakness and low lean mass using classifications from the Foundation for the National Institute of Health sarcopenia project.
Topics: Absorptiometry, Photon; Adjuvants, Immunologic; Aged; Body Composition; Bone Density Conservation Ag | 2015 |